Evidence map›Paper›PMID 37961168›Full record

ArticlebioRxiv : the preprint server for biology2024

Forecasting dominance of SARS-CoV-2 lineages by anomaly detection using deep AutoEncoders.

Simone Rancati, Giovanna Nicora, Mattia Prosperi, Riccardo Bellazzi, Marco Salemi, Simone Marini

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Simone RancatiDepartment of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.
Giovanna NicoraDepartment of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.
Mattia ProsperiDepartment of Epidemiology, College of Public Health and Health Professions, University of Florida, Gainesville, FL, USA.ORCID 0000-0002-9021-5595
Riccardo BellazziDepartment of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.
Marco SalemiEmerging Pathogens Institute, University of Florida, Gainesville, FL, USA.
Simone MariniDepartment of Epidemiology, College of Public Health and Health Professions, University of Florida, Gainesville, FL, USA.ORCID 0000-0002-5704-3533

Funding

A Phylodynamic Artificial Intelligence framework to predict evolution of SARS-CoV-2 variants of concern in Immunocompromised persons with HIV (PhAI-CoV)R01AI170187 · NIAID · UNIVERSITY OF FLORIDA · PI MARIA LUISA ALCAIDE, Deborah Lynne Jones · 2022 to 2026
$3.7M
NIAID NIH HHS R01 AI170187
6 · The paper itself

Abstract

The coronavirus disease of 2019 (COVID-19) pandemic is characterized by sequential emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, lineages, and sublineages, outcompeting previously circulating ones because of, among other factors, increased transmissibility and immune escape. We propose DeepAutoCoV, an unsupervised deep learning anomaly detection system to predict future dominant lineages (FDLs). We define FDLs as viral (sub)lineages that will constitute more than 10% of all the viral sequences added to the GISAID database on a given week. DeepAutoCoV is trained and validated by assembling global and country-specific data sets from over 16 million Spike protein sequences sampled over a period of about 4 years. DeepAutoCoV successfully flags FDLs at very low frequencies (0.01% - 3%), with median lead times of 4-17 weeks, and predicts FDLs ~5 and ~25 times better than a baseline approach For example, the B.1.617.2 vaccine reference strain was flagged as FDL when its frequency was only 0.01%, more than a year before it was considered for an updated COVID-19 vaccine. Furthermore, DeepAutoCoV outputs interpretable results by pinpointing specific mutations potentially linked to increased fitness, and may provide significant insights for the optimization of public health

Indexed as

Anomaly DetectionDeep LearningGenomic surveillanceSARS-CoV-2 (sub)lineagesSpike Protein Sequences

Identifiers

PMID37961168
PMCPMC10634784

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.